Do-Hyun Nam

Affiliations: 
Samsung Medical Center 
Google:
"Do-Hyun Nam"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mu Q, Chai R, Pang B, et al. (2023) Identifying predictors of glioma evolution from longitudinal sequencing. Science Translational Medicine. 15: eadh4181
Kim H, Sa JK, Kim J, et al. (2022) Recapitulated Crosstalk between Cerebral Metastatic Lung Cancer Cells and Brain Perivascular Tumor Microenvironment in a Microfluidic Co-Culture Chip. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2201785
Bastola S, Pavlyukov MS, Yamashita D, et al. (2020) Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nature Communications. 11: 4660
Lee WJ, Cho KR, Choi JW, et al. (2020) Gamma Knife Radiosurgery as a Primary Treatment for Nonfunctioning Pituitary Adenoma Invading the Cavernous Sinus. Stereotactic and Functional Neurosurgery. 1-7
Sa JK, Chang N, Lee HW, et al. (2020) Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biology. 21: 216
Koo H, Choi SW, Cho HJ, et al. (2020) Ethnic delineation of primary glioblastoma genome. Cancer Medicine
Oldrini B, Vaquero-Siguero N, Mu Q, et al. (2020) MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas. Nature Communications. 11: 3883
Liu J, Cho YB, Hong HK, et al. (2020) Molecular dissection of CRC primary tumors and their matched liver metastases reveals critical role of immune microenvironment, EMT and angiogenesis in cancer metastasis. Scientific Reports. 10: 10725
Choi SW, Cho HH, Koo H, et al. (2020) Multi-Habitat Radiomics Unravels Distinct Phenotypic Subtypes of Glioblastoma with Clinical and Genomic Significance. Cancers. 12
Lee HW, Chung W, Lee HO, et al. (2020) Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Medicine. 12: 47
See more...